汇添富国证生物医药ETF(159839)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
367,885.05 |
629,140.43 |
185,908.51 |
156,917.02 |
存出保证金 |
50,306.87 |
44,840.39 |
28,109.15 |
54,632.04 |
交易性金融资产 |
570,872,462.98 |
552,929,437.09 |
454,803,917.94 |
540,261,449.93 |
其中:股票投资 |
570,872,462.98 |
552,929,437.09 |
454,803,917.94 |
540,261,449.93 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
2,186,126.03 |
4,216,381.98 |
120,457.90 |
4,150,860.18 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
- |
- |
7,057.24 |
资产总计 |
579,266,901.85 |
564,893,176.50 |
460,537,898.46 |
548,140,647.61 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
4,052,619.67 |
4,375,504.58 |
2,539,527.97 |
4,768,381.77 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
232,588.12 |
231,819.34 |
194,013.32 |
225,817.25 |
应付托管费 |
46,517.62 |
46,363.88 |
38,802.66 |
45,163.44 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
103.58 |
637.34 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
145,587.50 |
241,623.36 |
194,475.27 |
303,483.35 |
负债合计 |
4,477,312.91 |
4,895,311.16 |
2,966,922.80 |
5,343,483.15 |
所有者权益 |
实收基金 |
1,665,735,165.00 |
1,656,735,165.00 |
1,443,735,165.00 |
1,221,735,165.00 |
未分配利润 |
-1,090,945,576.06 |
-1,096,737,299.66 |
-986,164,189.34 |
-678,938,000.54 |
所有者权益合计 |
574,789,588.94 |
559,997,865.34 |
457,570,975.66 |
542,797,164.46 |
负债及所有者权益总计 |
579,266,901.85 |
564,893,176.50 |
460,537,898.46 |
548,140,647.61 |